预变形量对2050 Al−Li合金显微组织和力学性能的影响

研究经不同轧制预变形处理(0~20%)后2050 Al−Li合金T8时效状态的显微组织演变和力学性能。通过透射电子显微镜(TEM)和扫描电子显微镜(SEM)对其显微组织进行表征。结果表明:随着预变形量的增加,晶粒尺寸沿ND方向显著变小,晶内畸变增大。位错等的缠结为T1相的析出提供了大量的形核位点。这导致析出相数量增多,析出相之间的距离缩小,从而提高了对位错运动的阻碍作用和合金强度。当预变形量为16%时,T1相数量密度和合金强度最高(屈服强度和抗拉强度分别达到568和584 MPa,伸长率为8.6%);当预变形量进一步增加到20%时,由于位错缠结,原子扩散通道减少,T1相数量的减少最终导致合金强度降低。

Clinical Observation of Bevacizumab Combined with S-1 in the Treatment of Pretreated Advanced Esophageal Carcinoma

Objective To investigate the clinical effects and safety of bevacizumab combined with S-1 as the second-line treatment of recurrent and/or metastatic esophageal cancer after chemoradiation. Methods Patients with recurrent or metastatic esophageal cancer after chemoradiation were treated with bevacizumab and S-1. Bevacizumab was used by intravenous infusion, 7.5mg/kg body weight on day 1; S-1 was used by oral at 80mg/m^2·d on day 1-14, 21 days as a cycle of treatment and repeated until either progressive disease or intolerable toxicity occurred. Chest CT were performed and RECIST 1.1 was used for response evaluation. Kaplan-Meier method was used for survival analysis. Side effects were recorded and analyzed. Results Totally 78 patients were enrolled in the study, including 67 squamous cell carcinoma and 11 adenocarcinoma histologically. The overall response(CR+PR) rate was 22.4%(17/76) and disease control(CR+PR+SD) rate was 61.8%(47/76) respectively. The median follow-up time was 20 months(range from 9 to 44 months). The median progression-free survival(PFS) was 4.9 months(95% CI 4.4-5.5) and the median overall survival(OS) was 8.1 months(95% CI 7.6-9.2). The median PFS and OS of patients with metastasis diseases were 6.2 months(95% CI 3.3 to 6.3) and 8.5 months(95% CI 5.8 to 11.2), where PFS was longer than that of patients with local regional recurrence(median 5.0 months, 95% CI 3.0 to 5.5, P=0.017) and OS was longer than that of patients with regional disease and metastasis(median 8.0 months, 95% CI 4.6 to 9.5, P=0.010). The common adverse effects were mild to moderate neutropenia(84.2%), grade Ⅰ -Ⅱ hand and foot syndrome(51.3%), grade Ⅰ -Ⅱ nausea(48.7%), mild epistaxis(30.1%) and mild vomiting(14.5%). Esophageal bleeding occurred in 7.9% of patients. One patient(1.3%) died from massive bleeding which was caused by esophageal perforation. Conclusion Bevacizumab combined with S-1 was effective and safe for esophageal cancer patients who had recurrent or metastatic diseases after chemoradiation.

Effect of non-isothermal aging on microstructure and properties of Al−5.87Zn−2.07Mg−2.42Cu alloys

The evolution of microstructure and properties of Al−5.87Zn−2.07Mg−2.42Cu alloys during non-isothermal aging was studied.The mechanical properties of the alloy were tested by stretching at room temperature.The results show that in the non-isothermal aging process,when the alloy is cooled to 140℃,the ultimate tensile strength of the alloy reaches a maximum value of 582 MPa and the elongation is 11.9%.The microstructure was tested through a transmission electron microscope,and the experimental results show that the GP zones andη'phases are the main strengthening precipitates.At the cooling stage,when the temperature dropped to 180℃,the GP zones were precipitated again.Besides,the experimental results show that the main strengthening phase during non-isothermal aging isη'phases.

Sorafenib in Liver Function Impaired Advanced Hepatocellular Carcinoma

Objective To explore the efficacy and safty of sorafenib in Child-Pugh class B to class C hepatocellular carcinoma （HCC）. Methods In this three-center open-label study from November 2011 to May 2013, we randomly assigned 189 patients with advanced Child-Pugh class B or C HCC patients into two groups, one group with 95 patient to receive sorafenib （400 mga time, twice a day） and the other group with 94 patients to receive best supportive care. The primary end points were progression-free survival and overall survival. Results The median progression-free survival was 2.2 months and 1.9 months in the sorafenib group and best supportive care group respectively （Hazard ratio in the sorafenib group, 0.55; 95% confidence interval, 0.40-0.75; P=O.O02）. The median overall survival was 4.0 months and 3.5 months in the sorafenib group and best supportive care group respectively （Hazard ratio in the sorafenib group, 0.48; 95% confidence interval, 0.35-0.68; P〈0.001）. The main adverse effect of sorafenib was rash and ache of the skin （in 51.7% patients）. The incidences of severe rash, diarrhea, and dry skin were 5.6%, 5.6%, and 2.2% in the sorafenib group. One patient reached partial response in the sorafenib group. Conclusions Sorafenib is safe in patients with liver function impaired advanced HCC. It is effective in terms of progression-free survival and overall survival compared with best supportive care. Liver functions are the important predictive factors.

Quantitative modeling, optimization, and verification of ^(63)Nipowered betavoltaic cells based on three-dimensional ZnO nanorod arrays

Betavoltaic cells(BCs)are promising self-generating power cells with long life and high power density.However,the low energy conversion efficiency(ECE)has limitations in practical engineering applications.Widebandgap semiconductors(WBGSs)with three-dimensional(3-D)nanostructures are ideal candidates for increasing the ECE of BCs.This paper proposes hydrothermally grown ZnO nanorod arrays(ZNRAs)for ^(63)Ni-powered BCs.A quantitative model was established for simulation using the parameter values of the dark characteristics,which were obtained from the experimental measurements for a simulated BC based on a Ni-incorporated ZNRAs structure.Monte Carlo(MC)modeling and simulation were conducted to obtain the values of the β energy deposited in ZNRAs with different nanorod spacings and heights.Through the simulation and optimization of the 3-D ZNRAs and 2-D ZnO bulk structures,the performance of the ^(63)Ni-powered BCs based on both structures was evaluated using a quantitative model.The BCs based on the 3-D ZNRAs structure and 2-D ZnO bulk structure achieved a maximum ECE of 10.1%and 4.69%,respectively,which indicates the significant superiority of 3-D nanostructured WBGSs in increasing the ECE of BCs.

High temperature mechanical properties and microstructure of die forged Al-5.87Zn-2.07Mg-2.42Cu alloy

The high temperature mechanical properties(250 ℃) and microstructure of a die-forged Al-5.87 Zn-2.07 Mg-2.42 Cu alloy after T6 heat treatment were investigated. High temperature tensile tests show that as the temperature increases from room temperature to 250 ℃, the ultimate tensile strength of the alloy decreases from 638 to 304 MPa, and the elongation rises from 13.6% to 20.4%. Transmission electron microscopy(TEM) and electron backscattered diffraction(EBSD) were applied for microstructure characterization, which indicates that the increase of tensile temperature can lead to the coarsening of precipitates, drop of dislocation density, and increase of dynamic recovery. After tensile testing at 250 ℃, a sub-grain structure composed of a high fraction of small-angle grain boundary is formed.

AZD9291-induced Acute Interstitial Lung Disease

To the Editor： A 32-year-old Chinese male patient with 1 week cough and dyspnea on exertion was presented to hospital. He was a metastatic lung adenocarcinoma patient with 3 years treatment history. In October 2012, the patient complained cough, short of breath, and thoracic computerized axial tomography scan （CAT-scan） revealed left lung hilum mass with the right lung multismall patches or opacities. Core needle biopsy on supraclavicular lymph nodes was performed and diagnosis of Stage IV （T3N3MIa） lung adenocarcinoma was made by radiologist, pathologist, and oncologist.